http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006024275-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29c5d94f49a24f38a2b3585bfbc3b9d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_139e3b8dfbbaa25cd312adff648b1dc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8420f4e5ce769d428e133047834b28c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_962f77d76779a9986e71a3f9993992f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9728c5217e88c82a9c528d083dfe7d6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605
filingDate 2005-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6962926d22aaf5026dcba180d34ce9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_436ee1e3b5ad98ff0c2cae72a63d9cfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca618d6034e14998fbdd70b659202f63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c62acf0e7d5f0860fe9d2d617596d24
publicationDate 2006-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006024275-A3
titleOfInvention Glp-1 and exendin related invention
abstract The invention relates to peptides derived from GLP-1 (Glucagon-like Peptide 1) and exendin-3 and/or exendin-4, which bind to GLP-1 receptors and may be used either marked or unmarked for the production of a means for diagnosis and therapy of benign and pernicious diseases in which GLP-1 receptor expression plays a role.
priorityDate 2004-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003232761-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9101144-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003073626-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16133831
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601242
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID494052
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16157882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426285290
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3772480
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3771769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601313
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71728421
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2641
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3772194
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396196
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397595

Total number of triples: 49.